Deal Announcements

EyeGate Pharmaceuticals Takes In $15 Million

Thursday, March 13, 2008 5:57:00 AM PDT | VentureDeal Staff

WALTHAM, MA -- EyeGate Pharmaceuticals, Inc. announced that it has secured $15 million in series C venture capital financing from a syndicate of international firms.

EyeGate has developed its EyeGate II delivery system that it claims can deliver ocular drugs without injections and other invasive methods of treatment.

Medicis Capital led the round, which included Ventech, Innoven Partenaires and The Nexus Group.  EyeGate will use the proceeds to enter into two Phase I studies for approval of its system.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1